Heart specialist Check-Ins could save lives in GP surgeries

NCT ID NCT06444711

Ongoing Disease control Sponsor: University of Leeds Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether having extra appointments with a heart specialist at a local GP practice helps people get better treatment for heart, kidney, metabolic, and lung conditions. 138 high-risk adults will either receive standard GP care or additional specialist reviews to optimize their medications according to national guidelines. After 6 months, researchers will check if the specialist group had more medication adjustments and better control of risk factors like blood pressure and cholesterol.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: NICE guideline-based treatment optimization
What this could lead to: If it works, this could show that adding specialist reviews in primary care helps more people get the right medications for their heart, kidney, and metabolic health.
What could go wrong: This is a small, early-stage trial with only 138 people, so results may not apply to everyone. It also relies on doctors following guidelines, which may not always lead to better outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation cardiovascular disorder kidney disorder lung disorder metabolic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES METABOLIC DISEASE PULMONARY DISEASE RENAL DISEASE

Contacts and locations

Locations

University of Leeds

Leeds, West Yorkshire, LS2 9JT, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.